Round Rock Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Round Rock Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$351K	Hold	2,219	–	–	0.05%	259
2026 Q1	$283K	Sell	2,219 -60	-3%	-$7.49K	0.04%	268
2025 Q4	$278K	Sell	2,279 -46	-2%	-$5.27K	0.04%	281
2025 Q3	$233K	Sell	2,325 -3,815	-62%	-$344K	0.04%	287
2025 Q2	$509K	Buy	+6,140	New	+$490K	0.09%	135
2024 Q1	–	Sell	-2,564	Closed	-$229K	–	194
2023 Q4	$229K	Buy	+2,564	New	+$190K	0.06%	169
2023 Q3	–	Sell	-2,958	Closed	-$246K	–	147
2023 Q2	$246K	Sell	2,958 -3,883	-57%	-$325K	0.09%	126
2023 Q1	$521K	Sell	6,841 -184	-3%	-$15.3K	0.2%	86
2022 Q4	$583K	Buy	7,025 +428	+6%	+$34.7K	0.24%	76
2022 Q3	$523K	Buy	6,597 +1,604	+32%	+$135K	0.24%	75
2022 Q2	$371K	Buy	4,993 +2,410	+93%	+$181K	0.17%	90
2022 Q1	$232K	Sell	2,583 -267	-9%	-$24.7K	0.09%	125
2021 Q4	$319K	Buy	+2,850	New	+$344K	0.14%	92
2021 Q3	–	Sell	-2,047	Closed	-$277K	–	69
2021 Q2	$277K	Sell	2,047 -910	-31%	-$120K	0.2%	53
2021 Q1	$401K	Buy	2,957 +1,284	+77%	+$192K	0.32%	37
2020 Q4	$235K	Buy	+1,673	New	+$214K	0.22%	46

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Round Rock Advisors's XBI Position: Q2 2026 in Review

Round Rock Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,219 shares worth $351K. The position accounts for 0.05% of the portfolio, ranked #259.

Round Rock Advisors first reported a position in XBI in Q4 2020 and has held it in 16 quarters since. The position peaked at $583K in Q4 2022. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Round Rock Advisors held 2,219 shares of State Street SPDR S&P Biotech ETF worth $351K as of Q2 2026.
Round Rock Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.05% of Round Rock Advisors's portfolio in Q2 2026, its #259 holding.
Round Rock Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 16 quarters since.
Round Rock Advisors's State Street SPDR S&P Biotech ETF position peaked at $583K in Q4 2022.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.